Intravitreous injections of vascular endothelial growth factor produce retinal ischemia and microangiopathy in an adult primate.
about
Chordin-like 1, a bone morphogenetic protein-4 antagonist, is upregulated by hypoxia in human retinal pericytes and plays a role in regulating angiogenesisThe clinical utility of aflibercept for diabetic macular edemaThe role of aflibercept in the management of diabetic macular edemaAlternative Medicine in Diabetes - Role of Angiogenesis, Oxidative Stress, and Chronic InflammationAngiopoietin-like 4 is a potent angiogenic factor and a novel therapeutic target for patients with proliferative diabetic retinopathyIntrachoroidal neovascularization in transgenic mice overexpressing vascular endothelial growth factor in the retinal pigment epitheliumVEGF localisation in diabetic retinopathy.Pegaptanib sodium for the treatment of neovascular age-related macular degeneration.Treatment of age-related macular degeneration.Emerging pharmacotherapies for diabetic macular edema.Vascular endothelial growth factor level in the serum of diabetic patients with retinopathy.Intravitreal bevacizumab treatment for retinal neovascularization and vitreous hemorrhage in proliferative diabetic retinopathyRole of pegaptanib sodium in the treatment of neovascular age-related macular degenerationOptimal current and future treatments for diabetic macular oedema.Identification of compounds that inhibit IGF-I signaling in hyperglycemia.Visual acuity and foveal thickness after vitrectomy for macular edema associated with branch retinal vein occlusion: a case series.Vitreous levels of pigment epithelium-derived factor and vascular endothelial growth factor in macular edema with central retinal vein occlusion.Vascular endothelial growth factor-B gene transfer exacerbates retinal and choroidal neovascularization and vasopermeability without promoting inflammation.The pathogenesis of edema in diabetic maculopathy.Vitreous inflammatory factors in macular edema with central retinal vein occlusion.Intravitreal Bevacizumab (Avastin) for Diabetic Retinopathy: The 2010 GLADAOF Lecture.VEGF-A165b is cytoprotective and antiangiogenic in the retinaComparison of three strains of diabetic rats with respect to the rate at which retinopathy and tactile allodynia develop.Characterization of a mouse model of hyperglycemia and retinal neovascularizationRandomized clinical trial evaluating intravitreal ranibizumab or saline for vitreous hemorrhage from proliferative diabetic retinopathy.Pegaptanib, a targeted anti-VEGF aptamer for ocular vascular disease.VEGF: From Discovery to Therapy: The Champalimaud Award Lecture.Visual prognosis and vitreous molecules after vitrectomy for macular edema with branch retinal vein occlusion.Intravitreal bevacizumab (Avastin) and panretinal photocoagulation in the treatment of high-risk proliferative diabetic retinopathy.The pathogenesis of diabetic retinopathy: old concepts and new questions.Targeting Neovascularization in Ischemic Retinopathy: Recent AdvancesAbnormal angiogenesis in diabetes mellitus.Early peripheral laser photocoagulation of nonperfused retina improves vision in patients with central retinal vein occlusion (Results of a proof of concept study).Retinal vein occlusion and macular edema - critical evaluation of the clinical value of ranibizumab.Medical treatment of diabetic retinopathy.Localisation of vascular endothelial growth factor and its receptors to cells of vascular and avascular epiretinal membranes.Role of vascular permeability factor/vascular endothelial growth factor in eye disease.Current intravitreal pharmacologic therapies for diabetic macular edema.Expression of thrombospondin-1 in ischemia-induced retinal neovascularizationInducible expression of vascular endothelial growth factor in adult mice causes severe proliferative retinopathy and retinal detachment
P2860
Q24652148-C171ACFE-E254-45A2-91C9-682F8CFD9593Q26783575-149C798E-8BDA-430A-87A4-C73C35BF79C8Q26798348-2E125DD7-0141-4B0D-978B-3954DB1DAC1DQ26801343-00796791-3564-45A6-98DB-74A13A732041Q28262797-0AE323B0-BEC1-405C-AB76-BF0A0949A24DQ28359761-164F346D-B1E3-4C98-A8F3-1A909CBDB1CAQ32035851-7550F4FF-16AA-40B5-9748-04DB0953F8C6Q33216197-DB5F1C64-A54B-4949-AEBE-11F8CAC0B0D4Q33226171-7BB1F063-E999-4D2C-AF07-295C9AA5DBB4Q33304852-8883F926-30CA-47FA-AFF9-6536230D3212Q33306345-840731BD-B819-42EA-8548-5BE86D7F9A1BQ33492339-EBCA6ACE-830B-44E4-BE3E-FE37A38572E0Q33492369-8161503E-8180-49C7-937E-6CE52766CF13Q33523991-C52F3DC7-29AB-499B-ACB6-BFB1AAAD0AC9Q33527441-0C7D3E62-9B76-49CE-A201-8361E73F830DQ33568145-4A9E0B57-B50E-40F9-B8E9-EA6794F723D1Q33806214-370C2D59-4B1A-4E5D-9593-5A7F194878C7Q33834038-CC6A08FB-738E-4C41-AB74-666C1AA40C8BQ33887327-6CD3A4CA-9DE9-4CDD-AF9C-0E7D697773F1Q33888116-767EE877-5743-462B-A31C-3AF456647DB6Q33902419-FC0AB916-E4DD-41BD-8154-5FE4FFCCF87BQ34022623-919D7673-30F0-48BC-8791-E289B357C3C2Q34081378-E457DA50-5C21-4832-8ECE-07EC74782A79Q34254645-7A0BB265-4A45-4578-A2B7-0C25789E012AQ34440571-4CC6A905-13C2-43D2-9D19-28E2BE286607Q34499843-73769334-E262-444D-813C-E6E8A27C2704Q34518374-47C059BE-A343-44F1-B585-19B630DD954DQ34616286-AC136C71-46A8-4255-ACB7-00747DCAA91AQ34621295-A1B2BABD-17A8-4351-8C20-67F8F64884C4Q34658478-E79C60BA-6970-44AC-A765-B1E320F59201Q34972210-36D43AFF-6892-4C82-899A-462772C10FE6Q35033890-E2E04188-EFFA-4987-8EF5-9E539E3421EDQ35068919-C6E5D944-1C18-49D8-A372-D2AC1712EF63Q35089799-FC431288-6164-4B84-BFE2-B998A6C472C9Q35175679-F3098270-B812-47E4-AE18-FDEC474033ECQ35298251-BA543CFA-6639-4D4B-B683-A28AE4A4E20EQ35300661-2CA180D8-44A2-47E1-972D-D4C81693597DQ35650268-5E8B6102-DB0B-45FB-A517-3DCE9B24ED5CQ35745334-83BE665F-CF89-4BA3-8AA5-5BC5AD5E2253Q35747297-3A248789-1547-4AD9-9E87-25001CBC12ED
P2860
Intravitreous injections of vascular endothelial growth factor produce retinal ischemia and microangiopathy in an adult primate.
description
1996 nî lūn-bûn
@nan
1996 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1996 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
name
Intravitreous injections of va ...... ngiopathy in an adult primate.
@ast
Intravitreous injections of va ...... ngiopathy in an adult primate.
@en
Intravitreous injections of va ...... ngiopathy in an adult primate.
@nl
type
label
Intravitreous injections of va ...... ngiopathy in an adult primate.
@ast
Intravitreous injections of va ...... ngiopathy in an adult primate.
@en
Intravitreous injections of va ...... ngiopathy in an adult primate.
@nl
prefLabel
Intravitreous injections of va ...... ngiopathy in an adult primate.
@ast
Intravitreous injections of va ...... ngiopathy in an adult primate.
@en
Intravitreous injections of va ...... ngiopathy in an adult primate.
@nl
P2093
P1433
P1476
Intravitreous injections of va ...... ngiopathy in an adult primate.
@en
P2093
Chatzistefanou K
Gragoudas ES
Jakobiec FA
Tolentino MJ
P304
P356
10.1016/S0161-6420(96)30420-X
P577
1996-11-01T00:00:00Z